San Diego, California -- Biotechnology company AnaBios has landed $5.1 million in new equity venture capital funding, according to an SEC regulatory filing.
AnaBios is a preclinical drug discovery company that is focused on utilizing human-relevant data in the fields of pain drug discovery, cardiovascular drug discovery and drug safety.
Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.
A total of 62 investors participated in the offering.
AnaBios is still seeking $3.25 million in additional equity investment, according to the filing.